Gottfrid Sjödahl
@GottfridSjodahl
Basic and translational cancer researcher. Cancer of the urinary bladder - Lund university, Malmö, Sweden
Massive work by @Pontus_Eriksson & Elena Aramendia @JMDiagn -#LundTax RF ssp for UC subtyping trained on ~900 cases - GitHub & R package so easy even I can use - Results in *all* external cohorts - In silico simulated effects of purity Check it out: t.ly/uiGD9
Really happy to share our review published today in Nature Reviews Urology! @NatRevUrol: rdcu.be/dYuu1 "Pre-treatment metastatic biopsy: a step towards precision oncology for urothelial cancer" Thanks to the amazing team of collaborators @AlexanderCoxMD…
Please consider giving your pathology images a forever home on WebPathology. Now you can load them directly from the site using Submit Images form. Give it a try. Webpathology.com: A Collection of Surgical Pathology Images #PathTwitter #PathX
New in press: Basal/squamous and Mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial @cs_groen doi.org/10.1016/j.anno…
In muscle-invasive bladder cancer, metastasis, while uncommon, is almost always fatal. A new Columbia-led study identified 2 FDA approved drugs- Rosiglitazone plus Trametinib- that kills aggressive cancer cells and shift tumors to a more benign type. cancer.columbia.edu/news/new-study…
I am proud that Bladder Cancer @BladderCaJrnl is in its 10th year of publication and it is now fully indexed in Pubmed! The journal is also Open Access making its cutting-edge articles on #bladdercancer freely available. @PubMedOnline bladdercancerjournal.com
Great to be in Bern for #IBCN2024 Looking forward to two days of great discussions on all things #BladderCancer and to meet colleagues from all around 🌎 @IBCN1997
Our paper just got covered by @Nature. We went under cover and contacted a "citation boosting" service. We managed to buy citations that appeared in a Scopus-indexed journal, providing conclusive evidence that citations can be bought in bulk!! nature.com/articles/d4158…
Our piece: The False Promise of Cancer Screening to Reduce Health Disparities. This was too provocative for medical journals, so we put it out in the lay press. Have a read.
While the desire to decrease health disparities is laudable, more cancer screening cannot accomplish that goal. Interventions must prioritize community needs over system needs. trib.al/qx0JhYg
No. This is not acceptable. The methods section is the single most important part of a scientific paper. If those details are relegated to supplementary materials, then it's not a scientific paper in a scientific journal.
Should journals publish how much they received for publishing a paper? In a recent letter published in Quantitative Science Studies (dx.doi.org/10.1162/qss_c_…), I suggest that any Article Processing Charge (#APC) that has been paid should be noted on the published article.…
Useful tool but this is unacceptable @biorender
Like, come tf on @BioRender biorender.com/academic-licen…
A teenager told me they don’t want to go into science (though he loves biology) because he wants to do something “creative”.. It’s funny how research seems dry from the outside, but full of curiosity and passion once you get into it.
🎉🔬 The 18th episode is out. Trastuzumab-Deruxtecan approved by FDA two days ago! Agnostic approval including bladder cancer 🚨‼️🎯 But only for Her2neu 3+ positive tumors! 👉 but what does 3+ actually mean? Similar to PD-L1 testing different assays and algorithms exist…
What a title! "Synthesizing AND gate minigene circuits based on CRISPReader for identification of bladder cancer cells" (2020) nature.com/articles/s4146… 2 big funding grants; 28 citations so far. Alas, a key image is stolen from an earlier papermill product. pubpeer.com/publications/3…
🌶️🌡️Summary of my uropathology for urologists and oncologists series! 👉check it out! and retweet if you like! @urotoday @OncoAlert @Uroweb @EAUYAUrology @EAU_YAUroTech @EauPatient @niklas_kluemper @onkowissen x.com/Markuseckstein…
Today I will start a new small series: Uropathology for urologists and uro-oncologists. @urotoday @OncoAlert @imedverse Let us start with my favorite topic: Urothelial Cancer! You will often hear urothelial cancer is a heterogeneous disease, but why ?
The currency of academic success is the peer reviewed scientific article. The actual currency of science is evidence that shifts epistemic beliefs about how the universe actually works. We should more tightly couple the actual currency of science with that of academic success.